Zealand Pharma A/S

Zealand Pharma A/S Stock

4.85P/E
€1.86BMarket capitalisation
DKK44.12Earnings
—Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Zealand Pharma AS is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. The company's product pipeline includes three product candidates in clinical development: glepaglutide, whichis being developed to treat short bowel syndrome or SBS; dasiglucagon formulated for use in a dual-hormone artificial pancreas system for diabetes management; and dasiglucagon for use in the treatment of congenital hyperinsulinism. The company has out-licensed a peptide program to Boehringer Ingelheim that has been moved ahead into early clinical development: a once-weekly novel dual-acting GLP-1/glucagon agonist for the treatment of obesity and/or Type 2 diabetes.

Zealand Pharma A/S is registered in the following country: Denmark (Exchange: DKCSE).

Key metrics

Key metrics and master data for the Zealand Pharma A/S stock.

Market capitalisation
€1.86B
P/E
4.85
P/B
0.81
P/S
3.28
P/CF
-10.08
Issued shares 72M Units

Return

Here you can see the performance of the Zealand Pharma A/S stock.

PeriodPerfor­mance
1 Week-13.29 %
1 Month-4.33 %
3 Months-33.47 %
6 Months-29.98 %
1 Year-58.50 %
YTD-55.70 %

Dividends

With an (expected) annual dividend of —, the current stock price results in a dividend yield of —.

Dividend type—
(Expected) annual dividend —
Dividend yield —

Splits

The table shows the splits of the Zealand Pharma A/S share.

DateRatio
No data available.

Which ETF contains the Zealand Pharma A/S stock?

The Zealand Pharma A/S stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Zealand Pharma A/S has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Zealand Pharma A/S stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.